HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Latest Conference Articles

The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.

Veeral Sheth, MD: Insights Into CST Fluctuations, Vision Outcomes with PDS Treatment

Veeral Sheth, MD: Insights Into CST Fluctuations, Vision Outcomes with PDS Treatment

July 15th 2022, 5:00pm

Overall 70% of the patients in both PDS with ranibizumab and ranibizumab alone had almost no retinal thickness fluctuations.

Concizumab Reduces Treated Bleeds in Hemophilia A or B with Inhibitors

Concizumab Reduces Treated Bleeds in Hemophilia A or B with Inhibitors

July 15th 2022, 10:00am

The phase 3 data presented at the ISTH 2022 Annual Congress show an 86% reduction of treated bleeds in patients with hemophilia A or B with inhibitors.

Faricimab Shows Efficacy in Treatment-Naive, Difficult-to-Treat Patients with nAMD

Faricimab Shows Efficacy in Treatment-Naive, Difficult-to-Treat Patients with nAMD

July 14th 2022, 7:00pm

Real-world patients showed improvement in visual acuity and anatomic parameters, but are still at an early time point in TRUCKEE study.

Pegcetacoplan Shifts Distribution Across Lesion Growth Quartiles In GA Treatment

Pegcetacoplan Shifts Distribution Across Lesion Growth Quartiles In GA Treatment

July 14th 2022, 6:00pm

Evidence of pegcetacoplan treatment effect observed in the distribution of patients across quartiles in both OAKS and DERBY.

Intravitreal Pegcetacoplan Well-Tolerated in Patients with Geographic Atrophy

Intravitreal Pegcetacoplan Well-Tolerated in Patients with Geographic Atrophy

July 14th 2022, 5:00pm

Monthly or every other month intravitreal pegcetacoplan reported to be tolerated in DERBY and OAKS trials.

Ellipsoid Zone Integrity a Key Factor for VA in Eyes with nAMD Without Fluid

Ellipsoid Zone Integrity a Key Factor for VA in Eyes with nAMD Without Fluid

July 14th 2022, 4:00pm

The best overall outcomes were attained in eyes without fluid and ellipsoid zone integrity preservation, investigators said.

The Adequate Evaluation Teams, Treatment Plans for Stevens-Johnson Syndrome

The Adequate Evaluation Teams, Treatment Plans for Stevens-Johnson Syndrome

July 2nd 2022, 3:00pm

Society of Dermatology Physician Assistants

Travis Vandergriff, MD, discusses the unique collaboration with ophthalmologists and urologists in the rare skin condition.

Tapinarof Cream Benefits Psoriasis Regardless of Baseline Disease Severity, Duration

Tapinarof Cream Benefits Psoriasis Regardless of Baseline Disease Severity, Duration

July 2nd 2022, 11:00am

Society of Dermatology Physician Assistants

An analysis of PSOARING 1 and 2 data show the topical therapy is efficacious across a wide spectrum of psoriatic disease and patient demographics.

Guselkumab Linked to Improved Psoriasis Treatment Continuation, Remission

Guselkumab Linked to Improved Psoriasis Treatment Continuation, Remission

June 30th 2022, 12:30am

Society of Dermatology Physician Assistants

An analysis suggests patients on the biologic fared better with adherence and outcomes than those on competitors including adalimumab.